Prescribing Newsletter
Everybody Dance Now – Moving Medicine
“Moving Medicine is the single most important advance in therapeutics in my 50 years in medicine. The benefit to harm […]
Wet Age-Related Macular Degeneration – Treatment Options
The CCGs in North Cumbria and the North East have commissioned this short film to help patients understand their options […]
Influenza – Antiviral Prescribing Guidance
Public Health England have published updated guidance on how to manage suspected or confirmed ‘flu using antiviral agents. – with […]
Antimicrobial Prescribing Guidance – NICE & PHE Update
Primary care guidance on management of common infections produced by Public Health England (PHE) has been used as the core […]
Medicinal Cannabis – Limits on Prescribing
The Chief Medical Officer, National Medical Director and Chief Pharmaceutical Officer have written to GPs to explain changes to regulations […]
Self-Monitoring of Blood Glucose in Type 2 Diabetes – little if any benefit for most
The NHS National Institute for Health Research has published a SIGNAL article highlighting a systematic review of 24 studies (including 5,454 […]
Bath Additives for Children with Eczema – No Benefit
A large (n = 482) well-conducted trial based in UK primary care has found “no evidence of clinical benefit of […]
Gabapentin & Pregabalin – to be Controlled Drugs in 2019
The Home Office has announced plans to classify both gabapentin and pregabalin as Class C controlled drugs in April 2019. […]
NHS England Press Release – Adalimumab Patent Expiry
NHS England have issued a Press Release announcing that the NHS is set “to save £150 million by switching to new […]